These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6403937)

  • 21. [The biological properties and virulence of a lysogenic strain from an SM-resistant strain of Mycobacterium tuberculosis].
    Nakano H; Sushida K
    Kekkaku; 1985 Nov; 60(11):577-84. PubMed ID: 3937930
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunogenic properties of Mycobacterium tuberculosis resistant to various tuberculostatic agents. Experimental study].
    Djurisić M; Drndarski K; Nesković V
    Glas Srp Akad Nauka Med; 1965; (18):69-74. PubMed ID: 4956328
    [No Abstract]   [Full Text] [Related]  

  • 23. [Biological properties of drug-sensitive Mycobacterium tuberculosis].
    Ginzburg TS; Klimenko MT; Sokalo SV
    Probl Tuberk; 1986; (7):58-60. PubMed ID: 3094003
    [No Abstract]   [Full Text] [Related]  

  • 24. [Virulence of tubercle bacilli of variou drug-resistance and enzymatic properties for guinea pigs].
    Kurdziel Z
    Gruzlica; 1968 Feb; 36(2):129-35. PubMed ID: 4969838
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the problem of the pathogenicity of resistant and atypical mycobacteria in relation to rabbits and chickens].
    Beliakova OI; Shlapak PT; Korzh BA
    Probl Tuberk; 1968; 46(3):56-60. PubMed ID: 4971316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sensitivity to 2d line preparations of Mycobacterium tuberculosis resistant to 1st line preparations].
    Kozulitsyna TI; Golyshevskaia VI
    Probl Tuberk; 1972; 50(11):62-6. PubMed ID: 4630566
    [No Abstract]   [Full Text] [Related]  

  • 27. [Virulence of catalase positive Mycobacterium tuberculosis with various characteristics of drug resistance].
    Zykov MP; Rule E; Poti SDzh
    Lab Delo; 1971; 4():228-9. PubMed ID: 4108217
    [No Abstract]   [Full Text] [Related]  

  • 28. [The virulence of Mycobacterium tuberculosis strains resistant to rifampicin. (Preliminary note)].
    Daddi G; Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):29-33. PubMed ID: 4996681
    [No Abstract]   [Full Text] [Related]  

  • 29. [Virulence of rifampicin-resistant tubercle bacilli for experimental animals (preliminary report)].
    Osato T; Shimizu H
    Kekkaku; 1972 May; 47(5):129-34. PubMed ID: 4625370
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rifampicin resistence and virulence of M. tuberculosis for guinea pigs].
    Schröder KH; Koperska C
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):112-3. PubMed ID: 4402403
    [No Abstract]   [Full Text] [Related]  

  • 31. [Virulence of rifampicin-resistent Mycobacterium tuberculosis].
    Klimenko MT
    Probl Tuberk; 1978 Jun; (6):73-7. PubMed ID: 97662
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological properties of Mycobacterium tuberculosis polyresistant to antitubercular agents].
    Klimenko MT
    Probl Tuberk; 1984 Dec; (12):60-4. PubMed ID: 6441166
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On methods to study the resistance of Mycobacterium tuberculosis to antibacterial preparations].
    Kovalev GK
    Probl Tuberk; 1967; 45(10):68-72. PubMed ID: 4979325
    [No Abstract]   [Full Text] [Related]  

  • 35. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 36. Virulence in the guinea pig of M. tuberculosis strains isolated from untreated patients in nine American countries.
    de Kantor IN; Lázaro L; Amadío G; Aparicio G; Blancarte L; Da Costa Santiago A; Kuffo D; Laszlo A; Masó Domínguez J; Reyes Gutiérrez JH
    Bull Pan Am Health Organ; 1983; 17(4):355-60. PubMed ID: 6199068
    [No Abstract]   [Full Text] [Related]  

  • 37. Is second-line anti-tuberculosis drug susceptibility testing reliable?
    Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606
    [No Abstract]   [Full Text] [Related]  

  • 38. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP
    Probl Tuberk; 1998; (4):4-5. PubMed ID: 9771024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistant Mycobacterium tuberculosis in Saudi Arabia.
    Arya SC
    Saudi Med J; 2002 Apr; 23(4):475. PubMed ID: 11953781
    [No Abstract]   [Full Text] [Related]  

  • 40. [Infectiousness and virulence of multidrug-resistant and drug susceptible tuberculosis in adult contacts].
    Palmero D; Cusmano L; Bucci Z; Romano M; Ruano S; Waisman J
    Medicina (B Aires); 2002; 62(3):221-5. PubMed ID: 12150003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.